ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 191 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,424,433 | -51.5% | 239,332 | -52.6% | 0.04% | -44.9% |
| Q3 2022 | $4,998,000 | -21.8% | 505,234 | -15.8% | 0.07% | -21.6% |
| Q2 2022 | $6,390,000 | +31.1% | 600,000 | +20.0% | 0.09% | +51.7% |
| Q1 2022 | $4,873,000 | -12.8% | 500,000 | +28.0% | 0.06% | -6.5% |
| Q4 2021 | $5,586,000 | -28.7% | 390,700 | 0.0% | 0.06% | -31.1% |
| Q3 2021 | $7,830,000 | +166.1% | 390,700 | +192.0% | 0.09% | +136.8% |
| Q2 2021 | $2,943,000 | – | 133,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $28,452,416 | 91.13% |
| Founders Fund Growth Management, LLC | 407,017 | $3,068,908 | 14.23% |
| Gruss & Co., LLC | 167,500 | $1,262,950 | 7.99% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $30,952,416 | 3.25% |
| Belmont Capital, LLC | 510,000 | $3,845,400 | 3.18% |
| Prosight Management, LP | 753,528 | $5,681,601 | 2.69% |
| Intellectus Partners, LLC | 872,483 | $6,578,520 | 2.08% |
| Casdin Capital, LLC | 2,520,000 | $19,000,800 | 1.56% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $13,022,958 | 1.50% |
| Orbimed Advisors | 4,180,768 | $31,522,991 | 0.62% |